OptiNose, Inc.
Hedge Funds Holdings
Last updated:
OptiNose, Inc.‘s stocks are currently a part of 40 hedge funds’ portfolios, which represents 57.93% of the total amount of its stocks outstanding. This makes up a total of 32.93M shares of OptiNose, Inc.. Compared to the previous quarter, the number grew by 13.33% or 3.87M shares more. As for the holding position changes, 42.5% (17) of current hedge fund investors increased the number of shares held, 17.5% (7) of current holders sold a part of the shares held, and 22.5% (9) closed the holdings completely. 9 hedge funds are new holders of OptiNose, Inc. stock in Q1 2022, it is 22.5% of total holders.
Hedge funds holding OptiNose (Q4 2017 – Q1 2022)
| Q4 2017 | 53 |
|---|---|
| Q1 2018 | 48 |
| Q2 2018 | 71 |
| Q3 2018 | 63 |
| Q4 2018 | 65 |
| Q1 2019 | 59 |
| Q2 2019 | 69 |
| Q3 2019 | 73 |
| Q4 2019 | 87 |
| Q1 2020 | 78 |
| Q2 2020 | 70 |
| Q3 2020 | 68 |
| Q4 2020 | 63 |
| Q1 2021 | 65 |
| Q2 2021 | 61 |
| Q3 2021 | 48 |
| Q4 2021 | 40 |
| Q1 2022 | 40 |
Hedge funds changes in OptiNose positions (Q4 2017 – Q1 2022)
| Q4 2017 | 53 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q1 2018 | 5 | 23 | 13 | 9 | -2 |
| Q2 2018 | 28 | 36 | 4 | 5 | -2 |
| Q3 2018 | 10 | 33 | 10 | 18 | -8 |
| Q4 2018 | 17 | 25 | 14 | 14 | -5 |
| Q1 2019 | 3 | 30 | 15 | 9 | 2 |
| Q2 2019 | 16 | 28 | 13 | 4 | 8 |
| Q3 2019 | 13 | 27 | 17 | 9 | 7 |
| Q4 2019 | 21 | 34 | 21 | 7 | 4 |
| Q1 2020 | 14 | 28 | 26 | 22 | -12 |
| Q2 2020 | 10 | 29 | 22 | 18 | -9 |
| Q3 2020 | 9 | 29 | 17 | 11 | 2 |
| Q4 2020 | 11 | 21 | 17 | 16 | -2 |
| Q1 2021 | 13 | 18 | 22 | 11 | 1 |
| Q2 2021 | 13 | 18 | 26 | 17 | -13 |
| Q3 2021 | 5 | 11 | 21 | 18 | -7 |
| Q4 2021 | 10 | 7 | 12 | 19 | -8 |
| Q1 2022 | 9 | 17 | 7 | 9 | -2 |
Hedge funds changes in OptiNose stock options (Q4 2017 – Q1 2022)
| Q4 2017 | 0 | 0 |
|---|---|---|
| Q1 2018 | 0 | 0 |
| Q2 2018 | 0 | 0 |
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 3,000 |
| Q2 2021 | 0 | 0 |
| Q3 2021 | 0 | 1,000 |
| Q4 2021 | 67,000 | 116,000 |
| Q1 2022 | 330,000 | 25,000 |